미국 · 보도자료 · Eli Lilly and Company · 2026-09-29 22:00
릴리 레타트루티드, 비만·2형 당뇨서 뚜렷한 체중 감량 및 혈당 감소
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over 80 weeks, with more than half no longer meeting the BMI criteria for obesity Participants with a baseline BMI of 35 or higher who took retatrutide 12 mg lost up to...
